Q2 EPS Estimates for OPKO Health Decreased by HC Wainwright
OPKO Health, Inc. (NASDAQ:OPK – Free Report) – Research analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of OPKO Health in a report released on Thursday, May 1st. HC Wainwright analyst Y. Chen now anticipates that the biotechnology company will post earnings per share of ($0.10) for the quarter, […]
